FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Ascend Laboratories Minocycline Hydrochloride Extended-Release Recall

Minocycline Hydrochloride Extended-Release Tablets, USP, 105 mg*, 30-count bottle, Rx O…

Ascend Laboratories LLC · Parsippany, NJ

Risk level
Class III
Reported by FDA
Feb 12, 2020
Recall ID
D-0827-2020
Check your lot numberHow we source this data

Summary

Ascend Laboratories recalled Minocycline Hydrochloride Extended-Release starting Jan 22, 2020. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0827-2020 on Feb 12, 2020. Reason: Failed Dissolution Specifications: low out of specification results for dissolution testing. Status: Terminated.

Why it was recalled

Failed Dissolution Specifications: low out of specification results for dissolution testing.

Product description

Minocycline Hydrochloride Extended-Release Tablets, USP, 105 mg*, 30-count bottle, Rx Only, Manufactured by: Alkem Laboratories Ltd., Mumbai - 400 013 India, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054, NDC 67877-438-30.

Lot numbers, UPCs & expiration codes

Lot #: 19140414, Exp 12/2020

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0827-2020
Classification
Class III
Status
Terminated
Recall initiated
Jan 22, 2020
FDA report date
Feb 12, 2020
Quantity
4728 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Ascend Laboratories LLC

Original FDA data

Every field from FDA enforcement report D-0827-2020, exactly as published.

Show all FDA fields
City
Parsippany
State
NJ
Status
Terminated
Country
United States
Event ID
84750
Address
339 Jefferson Rd Ste 101
Code information
Lot #: 19140414, Exp 12/2020
Postal code
07054-3707
Report date
Feb 12, 2020
Product type
Drugs
Recall number
D-0827-2020
Classification
Class III
Recalling firm
Ascend Laboratories LLC
Product quantity
4728 bottles
Termination date
Oct 27, 2021
Reason for recall
Failed Dissolution Specifications: low out of specification results for dissolution testing.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Minocycline Hydrochloride Extended-Release Tablets, USP, 105 mg*, 30-count bottle, Rx Only, Manufactured by: Alkem Laboratories Ltd., Mumbai - 400 013 India, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054, NDC 67877-438-30.
Distribution pattern
Nationwide in the USA
Recall initiation date
Jan 22, 2020
Initial firm notification
Letter
Center classification date
Feb 5, 2020

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0827-2020, published Feb 12, 2020. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls